ArticleArchives of virology2025
Genetic characterization of highly pathogenic avian influenza A/H5N8 virus isolated from commercial poultry farms in Egypt reveals zoonotic potential.
Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A One Health Computational Framework for Identifying PA Endonuclease Inhibitors Against Contemporary H5N1 Avian Influenza.Veterinary sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Highly pathogenic avian influenza (HPAI) H5N8 virus, first identified in late 2016 in Egypt, continues to circulate and has replaced the previously dominant HPAI H5N1 virus of clade 2.2.1. In this study, HPAI H5N8 was detected on 23 commercial poultry farms in Egypt. Complete genome sequences of three isolates collected in 2021 were obtained using next-generation sequencing (NGS) and subjected to genetic characterization. Phylogenetic analysis showed these isolates to belong to clade 2.3.4.4b, comprising two genotypes: EA-2021-Q and EA-2020-A. Molecular analysis of the haemagglutinin (HA) protein revealed the presence of T156A and V538A substitutions in the duck isolate and an N183S substitution in the chicken isolate. Several additional nonsynonymous mutations were identified, including 147I and 504V in the PB2 protein, 127V, 672L, and 550L in the PA protein, 64F and 69P in the M2 protein, and 42S in the NS1 protein. Comparative analysis of HA antigenic sites between these isolates and the human vaccine against H5N8 revealed four nonsynonymous mutations: S141P, A154N, D45N, and V174I. Notably, the HA sequences of the studied isolates shared 98.7-99.4% amino acid sequence identity, and the NA sequences shared 96.1-97.1% identity to those of the 2.3.4.4b candidate human H5N8 vaccine strain (CVV) A/Astrakhan/3212/2020-like. These findings underscore the importance of continuous monitoring of the genetic evolution of avian influenza viruses to guide updates of candidate vaccine strains. Furthermore, the high similarity between the detected isolates and a zoonotic Russian H5N8 wild-type strain highlights the potential risk of cross-species transmission and possible human infection.
Indexed as
Identifiers
41417225What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.